Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Legrand

Showing results (41-50 of 143) with videos related to

Pageof 15
Sort By:
Revue Medicale De Liege|January 1, 1995
[Moderate hypercholesterolemia and coronary disease: the MAAS study and the 4S study]C Martinez, V Legrand, H Kulbertus
Revue Medicale De Liege|March 8, 2011
[Interventional options in modern treatment of hypertrophic obstructive cardiomyopathy]F Dulguerov, M A Radermecker, V Legrand
Revue Medicale De Liege|December 5, 2008
[Benefit-risk ratio of coronary drug-eluting stents. 1st part: evaluation in the global population]A Nyssen, V Legrand, A J Scheen
Revue Medicale De Liege|June 12, 2009
[Incidence of restenosis and cardiac events after coronary angioplasty in diabetic patients: reduction by systemic pharmacological approaches]A Nyssen, V Legrand, A J Scheen
Revue Medicale De Liege|January 14, 2005
[Percutaneous coronary angioplasty in diabetic patients. Part II: hopes based on endovascular prosthesis]F Warzée, V Legrand, A J Scheen
Revue Medicale Suisse|September 24, 2009
[Prevention of restenosis and of cardiac events after coronary angioplasty in diabetics]A Nyssen, V Legrand, A J Scheen
Revue Medicale De Liege|December 30, 2004
[Percutaneous transluminal coronary angioplasty (PTCA) in diabetic patients. Part 1: failure due to restenosis after simple PTCA]F Warzée, V Legrand, A J Scheen
Revue Medicale De Liege|January 14, 2005
[Image of the month. Muscular fibrodysplasia of the renal artery]O Gach, L A Piérard, V Legrand
Revue Medicale De Liege|January 22, 2005
[Percutaneous coronary angioplasty in diabetic patients: new prospects with drug-eluting stents]F Warzee, V Legrand, A J Scheen
Revue Medicale De Liege|December 31, 2008
[Benefit-risk ratio of coronary drug-eluting stents: 2nd part: evaluation in the diabetic population]A Nyssen, V Legrand, A J Scheen
Pageof 15

Showing results (41-50 of 143) with videos related to

Sort By:
Pageof 15
Revue Medicale De Liege|January 1, 1995
[Moderate hypercholesterolemia and coronary disease: the MAAS study and the 4S study]C Martinez, V Legrand, H Kulbertus
Revue Medicale De Liege|March 8, 2011
[Interventional options in modern treatment of hypertrophic obstructive cardiomyopathy]F Dulguerov, M A Radermecker, V Legrand
Revue Medicale De Liege|December 5, 2008
[Benefit-risk ratio of coronary drug-eluting stents. 1st part: evaluation in the global population]A Nyssen, V Legrand, A J Scheen
Revue Medicale De Liege|June 12, 2009
[Incidence of restenosis and cardiac events after coronary angioplasty in diabetic patients: reduction by systemic pharmacological approaches]A Nyssen, V Legrand, A J Scheen
Revue Medicale De Liege|January 14, 2005
[Percutaneous coronary angioplasty in diabetic patients. Part II: hopes based on endovascular prosthesis]F Warzée, V Legrand, A J Scheen
Revue Medicale Suisse|September 24, 2009
[Prevention of restenosis and of cardiac events after coronary angioplasty in diabetics]A Nyssen, V Legrand, A J Scheen
Revue Medicale De Liege|December 30, 2004
[Percutaneous transluminal coronary angioplasty (PTCA) in diabetic patients. Part 1: failure due to restenosis after simple PTCA]F Warzée, V Legrand, A J Scheen
Revue Medicale De Liege|January 14, 2005
[Image of the month. Muscular fibrodysplasia of the renal artery]O Gach, L A Piérard, V Legrand
Revue Medicale De Liege|January 22, 2005
[Percutaneous coronary angioplasty in diabetic patients: new prospects with drug-eluting stents]F Warzee, V Legrand, A J Scheen
Revue Medicale De Liege|December 31, 2008
[Benefit-risk ratio of coronary drug-eluting stents: 2nd part: evaluation in the diabetic population]A Nyssen, V Legrand, A J Scheen
Pageof 15